Abstract:Abstract Background Men who have sex with men (MSM) have been disproportionately affected by HIV-1 since the beginning of the AIDS pandemic, particularly in the USA and Europe. Compared to men who have sex with women (MSW), MSM have a distinct fecal microbiome regardless of HIV-1 infection. However, it is unclear whether the MSM-associated gut microbiome affects the susceptibility and progression of HIV-1 infection. We studied fecal microbiome profiles, short-chain fatty acids, and blood plasma inflammatory cytokines of 109 HIV-1 seroconverters (SC) from the early, 1984–1985 phase of the HIV-1 pandemic in the Multicenter AIDS Cohort Study (MACS) before and after HIV-1 infection compared to 156 HIV-1-negative MACS MSM (negative controls [NC]). Results We found that family Succinivibrionaceae , S24-7, Mogibacteriaceae, Coriobacteriaceae , and Erysipelotrichaceae were significantly higher ( p <0.05), whereas Odoribacteraceae , Verucomicrobiaceae , Bacteroidaceae , Barnesiellaceae , and Rikenellaceae were significantly lower ( p <0.05), in SC before HIV-1 infection compared to NC. At the species level, Prevotella stercorea , Eubacterium biforme , and Collinsella aerofaciens were significantly higher ( p <0.05), and Eubacterium dolichum, Desulfovibrio D168, Alistipes onderdonkii, Ruminococcus torques , Bacteroides fragilis, Bacteroides caccae, Alistipes putredinis , Akkermansia muciniphila , Bacteroides uniformis , and Bacteroides ovatus were significantly lower ( p <0.05) in SC before HIV-1 infection compared to NC. After HIV-1 infection, family Prevotellaceae and Victivallaceae and species Bacteroides fragilis and Eubacterium cylindroides were significantly higher ( p <0.05) in SC who developed AIDS within 5 years compared to the SC who were AIDS free for more than 10 years without antiretroviral therapy (ART). In addition, family Victivallaceae and species Prevotella stercorea , Coprococcus eutactus , and Butyrivibrio crossotus were significantly higher ( p <0.05) and Gemmiger formicilis and Blautia obeum were significantly lower ( p <0.05) after HIV-1 infection in SC who developed AIDS within 5–10 years compared to the SC who were AIDS-free for more than 10 years without ART. Furthermore, plasma inflammatory cytokine levels of sCD14, sCD163, interleukin 6, and lipopolysaccharide binding protein were significantly higher in SC with p <0.05 before HIV-1 infection compared to NC. Conclusions Our results suggest that pathogenic changes in the gut microbiome were present in MSM several months prior to infection with HIV-1 in the early phase of the AIDS pandemic in the USA. This was associated with increased inflammatory biomarkers in the blood and risk for development of AIDS.

Gut Microbiome, Short-Chain Fatty Acids, and Mucosa Injury in Young Adults with Human Immunodeficiency Virus Infection

Oral Microbiota is Associated with Immune Recovery in Human Immunodeficiency Virus-Infected Individuals

Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients

Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: an Observational Study in A Chinese Population

Intestinal Mucosal Microbiota Composition of Patients with Acquired Immune Deficiency Syndrome in Guangzhou, China.

Alterations in the Gut Microbiota of Patients with Acquired Immune Deficiency Syndrome

Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSM

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection

A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects

Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals

Analysis of the gut microbiota and fecal metabolites in people living with HIV

Gut Microbiome Changes Associated with Epithelial Barrier Damage and Systemic Inflammation during Antiretroviral Therapy of Chronic SIV Infection

Characterization of intestinal fungal community diversity in people living with HIV/AIDS (PLWHA)

Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV

Gut epithelial barrier and systemic inflammation during chronic HIV infection

Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation

Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation

Crosstalk between human immunodeficiency virus infection and salivary bacterial function in men who have sex with men

Integrated analysis of gut and oral microbiome in men who have sex with men with HIV Infection

Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.

Novel Immunological Markers of Intestinal Impairment Indicative of HIV-1 Status and/or Subclinical Atherosclerosis